Hetero's Covid-19 oral drug gets WHO pre-qualification
Leading pharmaceutical company Hetero on Monday announced that it has received the World Health Organization Prequalification of Medicines Programme (WHO PQ) approval for its generic version of Covid-19 oral antiviral treatment candidate ...